Skip to content

Newsroom

type
year
Illustration image.png

Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

11/19/2024 Press release
orionfi_menopaussi_tyopaikalla_paakuva_1500x844.jpg

Shattering the silence: menopause awareness as key to more inclusive work environments

11/12/2024 Orion and Society
orionfi_potilastarina_keuhkoahtauma_paakuva_1500x844.jpg

Päivi Kuoppamäki was diagnosed with COPD at the age of 40: “I avoid situations where I might start laughing”

11/4/2024 Your Health
Illustration image.png

Orion Corporation: Managers’ transactions – Henrik Stenqvist

11/1/2024 Managers transactions
orionfi_jobshadow_paakuva_1500x844.jpg

18-year-old Pyry shadowed the SVP for R&D for a day – “I would love to do socially significant work”

10/30/2024 Orion and Society
Illustration image.png

Orion Group Interim Report January–September 2024

10/29/2024 Stock exchange release
Illustration image.png

Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule

10/24/2024 Stock exchange release
Illustration image.png

Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024

10/15/2024 Press release
Illustration image.png

Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU

10/14/2024 Press release
Climate header 2.jpg

Committed to science and sustainability: What do Orion’s science-based climate targets mean?

10/7/2024 Sustainability
orionfi_potilastarina_rintasyopa_paakuva_1500x844.jpg

Kerly Hiltunen was diagnosed with metastatic breast cancer: “I am very grateful to have been able to live this long”

10/1/2024 Your Health
Illustration image.png

Orion’s near-term climate targets approved by the Science Based Targets initiative

9/30/2024 Press release
2024_06_Faasi_004_1500x844.jpg

Jenni Laukkanen: At Orion, my views are valued and that has made me more confident

9/26/2024 We are Orion
Illustration image.png

Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster

9/26/2024 Press release
Illustration image.png

Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology

9/25/2024 Press release
orionfi_migreeni_paakuva_1500x844.jpg

Working with a migraine is exhausting – are better migraine treatments just around the corner?

9/24/2024 Your Health
Illustration image.png

213,285 Orion Corporation A shares converted into B shares

9/20/2024 Stock exchange release
2024_06_Faasi_017_1500x844.jpg

Alessandra Rafkin: Everything I have learnt as a Phase1 trainee at Fermion will give me a strong foundation for my future career

9/19/2024 We are Orion